CEACAM1 and metabolic dysfunction-associated steatohepatitis: Likewise, in collaboration with Drs. A. Zarrinpar and S. Duarte from the University of Florida, we have shown that hepatic CEACAM1 levels are lower in liver biopsies of patients with MASH than normal subjects regardless of gender, ethnicity and race[63].